Emerge PTCA Dilatation Catheter gets CE mark approval


Boston Scientific has announced CE mark and European market launch of the Emerge PTCA Dilatation Catheter for coronary angioplasty and stenting procedures. 

The Emerge catheter includes a 1.2mm diameter balloon option that features an ultra-low 0.017” tip profile and low crossing profiles designed to cross tight lesions. The Emerge 1.2mm balloon also employs a durable balloon material that provides high rated burst pressure (18 ATM) for sizing flexibility. The Emerge catheter platform offers a reduced, low-friction shaft profile which allows for simultaneous use of two Monorail balloon catheters in a 6F guide catheter and two OTW balloon catheters in an 8F guide catheter.

“The Emerge catheter combines several innovative balloon technologies in a single versatile platform,” said Jean Fajadet, Clinique Pasteur, Toulouse, France, who performed the first procedure in Europe with the Emerge PTCA Dilatation Catheter. “The result is a functional catheter with a low profile and excellent deliverability to facilitate the navigation and crossing of challenging coronary lesions.”

The Emerge 1.2mm and 1.5mm PTCA Dilatation Catheters are currently under review by the US Food and Drug Administration (FDA), and are not available for sale in the United States.